Post by
prophetoffactz on Aug 26, 2024 10:42am
Instant success
Put yourself in Gilles shoes.The more information he puts in the public domain the greater the risk of being taken over for peanuts.
Are we about to see 'instant' success, in a sense?
From a 10L PGX pilot facility to an instant 10X as the company may go from 10L to 50L to 100L instantly in the public's eye. Health Canada approval is expected shortly tied to 50L production which was also expected to provide material for potential partners. The 100L facility is the decision-point for the mass industrialization of PGX. The company also designed an animal trial protocol to further strengthen the argument for the immune booster and a comprehensive article could be published imminently with McMaster for PGX-YBG/fibrosis. All of this could mean a quantum leap in the market's understanding of PGX and its on NASDAQ.
While we've seen no preclinical or clinical data to date for the avenanthramide pill will we soon jump to our first human data as the multi-dose component of the clinical trial is initiated. CSCI has also investigated avenanthramide with newer PGX carriers and PGX is near critical development milestones. Will see soon have a greater understanding concerning the long-term potential of avenanthramide; including with PGX? The Angiogenesis Foundation has also published wound healing results and the company has also made an avenanthramide chewy bar, oat flour, and chewy bar. The avenanthemide franchise and potential may soon be much clearer.
There has also been talk of a wound healing franchise given the results from the Angiogenesis Foundation which Gilles called a home run.
If the pediatric diagnostic trial is a success a licensing deal could further strengthen the company financially.
Ronnie Miller has said that company is now optimized to bring "transformational" products to market. From a 10L pilot PGX facility and no preclinical data on the pill we may soon find the company in a new much stronger position and any takeover bid would have to recognize it. There is also a potential wound healing franchise and the other pipeline products before key milestones.